What is the recommended treatment for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for H. pylori Infection

Bismuth quadruple therapy for 14 days is the recommended first-line treatment for H. pylori infection, especially in areas with high clarithromycin resistance (>15-20%). 1

First-Line Treatment Options

Bismuth Quadruple Therapy (Preferred)

  • Components:
    • Proton pump inhibitor (PPI) at high dose twice daily
    • Tetracycline
    • Metronidazole or amoxicillin
    • Bismuth salt
  • Duration: 14 days 1

This regimen is particularly important in regions with high clarithromycin resistance, which has become increasingly common worldwide. The traditional clarithromycin-based triple therapy is no longer recommended as first-line treatment in areas with high clarithromycin resistance due to unacceptably high failure rates 1.

Key Treatment Principles

  1. Treatment duration: 14-day regimens are superior to 7-day regimens, improving eradication rates by approximately 5% 1

  2. PPI dosing: High-dose PPI (twice daily) significantly increases eradication success by 6-10% 1

  3. Post-treatment testing: Eradication should be confirmed 4-8 weeks after completion of therapy using either urea breath test or validated monoclonal stool antigen test 1

Second-Line Treatment

If first-line therapy fails, the following options are recommended:

  • Bismuth quadruple therapy (if not used initially) for 14 days
  • Levofloxacin-containing triple therapy (PPI, levofloxacin, and amoxicillin) 1

However, levofloxacin-containing regimens should be used with caution due to rising resistance rates 1.

Third-Line Treatment

After two treatment failures, therapy should be guided by antimicrobial susceptibility testing whenever possible 1. Options include:

  • Rifabutin-based triple therapy
  • High-dose dual amoxicillin-PPI therapy 1

Specific Regimens

H. pylori Dual Therapy

  • 1 gram amoxicillin three times daily (every 8 hours)
  • 30 mg lansoprazole three times daily (every 8 hours)
  • Duration: 14 days 2

H. pylori Triple Therapy

  • 1 gram amoxicillin twice daily
  • 500 mg clarithromycin twice daily
  • 30 mg lansoprazole twice daily
  • Duration: 14 days 2

Special Populations

Patients with Penicillin Allergy

  • Metronidazole can replace amoxicillin in most regimens 1

Patients with Renal Impairment

  • Amoxicillin dosing may need adjustment based on glomerular filtration rate 1, 2
  • For severe renal impairment (GFR 10-30 mL/min): 500 mg or 250 mg every 12 hours
  • For very severe renal impairment (GFR <10 mL/min): 500 mg or 250 mg every 24 hours 2

Common Pitfalls to Avoid

  1. Using clarithromycin-based therapy empirically in high-resistance regions - This leads to treatment failure and further resistance development 1

  2. Short treatment duration - 7-day regimens have lower success rates than 14-day regimens 1

  3. Inadequate PPI dosing - Using standard once-daily PPI dosing reduces efficacy 1

  4. Reusing previously failed antibiotics - This practice should be avoided due to likely resistance 1

  5. Not confirming eradication - All patients should undergo post-treatment testing to confirm successful eradication 1

The landscape of H. pylori treatment has evolved significantly due to increasing antibiotic resistance, particularly to clarithromycin. This has rendered the once-standard triple therapy ineffective in many regions, necessitating more complex treatment approaches 3, 4.

References

Guideline

H. pylori Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.